Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands

K-Number: K212977 · 2022-02-17

Decision Date2022-02-17
Product CodeDQO
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands is a medical device manufactured by Cordis Corporation. It received FDA 510(k) clearance on 2022-02-17 under approval number K212977. The device is classified under product code DQO. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands?

SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands is a medical device that received FDA 510(k) clearance on 2022-02-17. It is manufactured by Cordis Corporation. The 510(k) number is K212977.

When was SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands approved by the FDA?

SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands received FDA 510(k) clearance on 2022-02-17, under approval number K212977.

What company makes SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands?

SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands is manufactured by Cordis Corporation.

What is the FDA product code for SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands?

The FDA product code for SUPER TORQUE MB Angiographic Catheter with Radiopaque markerbands is DQO.

Other Devices by Cordis Corporation

View all 8 devices →

Related Devices (Code: DQO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.